about header
Press Releases
Print Text Size
  • 2/11/09 8:51 am EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corp. (NASDAQ: GENZ) today announced solid fourth-quarter revenue and earnings growth and provided guidance for 2009 that underscored its positive outlook for the year.

    more...
  • 2/3/09 1:28 pm EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corp. (NASDAQ: GENZ) announced today that its global corporate headquarters, Genzyme Center, is the 2008 recipient of the Harleston Parker Medal, a unique design award presented periodically by the Boston Society of Architects (BSA) and the City of Boston.

    more...
  • 1/13/09 12:02 pm EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corp. (NASDAQ: GENZ) announced today that revenue rose 13 percent in the fourth quarter of 2008 and 21 percent for the year. Fourth quarter estimated revenues were $1.17 billion, reflecting an approximate negative $39 million impact of foreign exchange, compared with $1.04 billion in the same period in 2007. For the year, revenue grew to $4.6 billion from $3.8 billion in 2007. Genzyme expects fourth quarter non-GAAP earnings per diluted share of between $1.01 and $1.04.

    more...
  • 1/12/09 9:00 am EST
    CAMBRIDGE, Mass. & CARLSBAD, Calif.--

    CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that they have begun two new studies of mipomersen, a novel lipid-lowering drug in late-stage development, and a third is currently screening patients. These three trials will provide additional data on mipomersen in high-risk patient populations.

    more...
  • 1/7/09 9:43 am EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) announced today that Chairman and Chief Executive Officer Henri A. Termeer will present at the 27th Annual JPMorgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco. Mr. Termeer will provide an overview of the company and describe Genzyme’s strategy to deliver sustainable growth through 2011 and beyond. The presentation will take place on Tuesday, January 13, 2009, at 9:00 a.m. (PST).

    more...
  • 12/15/08 4:59 pm EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) announced today that the U.S.

    more...
  • 12/11/08 4:45 pm EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ), the Broad Institute of Harvard and MIT, and Medicines for Malaria Ventures (MMV) today announced that its scientists presented several posters, in addition to an oral presentation, this week at the American Society of Tropical Medicine and Hygiene (ASTMH) in New Orleans, La. The research focused on progress these organizations have made through their ongoing collaboration to develop improved treatment therapies for malaria.

    more...
  • 12/9/08 4:50 pm EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that the FDA’s Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 – 0) in favor of approval without conditions of Synvisc-One™ (hylan G-F 20).

    more...
  • 12/8/08 7:45 pm EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today reported preliminary data on secondary endpoints from its CLASSIC II investigational study examining the safety and effectiveness of Clolar® (clofarabine) as a single agent to treat high-risk adult patients with acute myeloid leukemia (AML).

    more...
  • 12/5/08 10:19 am EST
    CAMBRIDGE, Mass.--

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that its Premarket Approval (PMA) application supplement for Synvisc-One (hylan G-F 20) will be discussed this Tuesday, December 9th, at a public meeting of the FDA’s Orthopaedic and Rehabilitation Devices Advisory Committee in Gaithersburg, Maryland.

    more...
Contact Us
 

Media Resources

Tweets

Social Media

Business Wire NewsHQ℠
infoBox